Investment Analysts’ upgrades for Wednesday, August 30th:

CrossAmerica Partners (NYSE:CAPL) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Cloudera (NASDAQ:CLDR) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Forward Pharma A/S (NASDAQ:FWP) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Gigamon (NYSE:GIMO) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Luxfer Holdings PLC (NYSE:LXFR) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Marriott International (NASDAQ:MAR) was upgraded by analysts at Wolfe Research from a peer perform rating to an outperform rating.

PBF Logistics (NYSE:PBFX) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Prospect Capital Corporation (NASDAQ:PSEC) was upgraded by analysts at Raymond James Financial, Inc. from an underperform rating to a market perform rating.

Roadrunner Transportation Systems (NASDAQ:RRTS) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Six Flags Entertainment Corporation New (NYSE:SIX) was upgraded by analysts at Hilliard Lyons from a neutral rating to a buy rating.

Total System Services (NYSE:TSS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $76.00 target price on the stock. According to Zacks, “Shares of Total System have outperformed its industry year to date. The company is set to benefit from its robust NetSpend business, while the TransFirst acquisition will support its merchant acquiring business. A number of acquisitions made by it have contributed to overall growth. Its second-quarter earnings beat the Zacks Consensus Estimate and grew year over year.  Following strong performance in first-half of the year, the company pulled up its 2017 earnings guidance, which instills investors' confidence. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 1.5% upward over the last 60 days. “

Ubisoft Entertain (NASDAQ:UBSFY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $15.00 target price on the stock. According to Zacks, “Ubisoft Entertainment operates in parts of Europe, Canada and the United States and its primary activities are the production, publishing and distribution of interactive entertainment products. Products include video games, educational and cultural software, cartoons, literary, multimedia, audio-visual products, cinematographic and television works. Some of its brands are Driver, Anno, Endwar and Tom Clancy. “

Uranium Energy Corp. (NYSEMKT:UEC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.50 target price on the stock. According to Zacks, “Uranium Energy Corp is a US-based junior resource company with the objective of becoming a near-term ISR uranium producer in the United States. The Company controls one of the largest historical uranium exploration and development databases in the US. Through the use of these databases, the Company has acquired advanced uranium properties throughout the southwestern US. The operational management is comprised of pre-eminent uranium mining and exploration professionals, whose collective experience in the uranium mining industry gives the Company ongoing uranium mine-finding and uranium mine development expertise. Uranium Energy Corp is well positioned to capitalize on the current alternative energy boom. “

Unite Group (NASDAQ:UTGPF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $8.50 target price on the stock. According to Zacks, “The Unite Group plc is a property investment company. It develops and operates student accommodation primarily in the United Kingdom. The Unite Group plc is headquartered in Bristol, the United Kingdom. “

VBI Vaccines (NASDAQ:VBIV) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA. “

Versartis (NASDAQ:VSAR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Versartis, Inc. operates as a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The Company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase 2a clinical trials for the treatment of growth hormone deficiency. Versartis, Inc. is headquartered in Redwood City, California. “

Walgreens Boots Alliance (NASDAQ:WBA) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.